Category : Search result: Odisha Pharmaceuticals and Medical Devices Policy 2025


Glenmark Recalls Blood Pressure Drug Ziac in US

Glenmark Pharmaceuticals recalls over 11,100 bottles of Ziac tablets in the US due to cross-contamination with a cholesterol drug. Check lot numbers and consult your doctor.

Unnao Nursing College Protest Over 'Bad Touch' Allegation

A nursing student in Unnao accused the medical superintendent of inappropriate touch during a checkup on Nov 17. The allegation sparked massive campus protests, leading to police intervention. Read the full story.

Odisha Approves Pharma & Medtech Policy 2025

Odisha's new Pharma & Medtech Policy 2025 aims to make the state a strategic hub for healthcare manufacturing. The policy includes plans for dedicated industrial parks and a roadmap aligned with India's 2047 vision. Read more.

RIMS cancels MBBS admission over fake caste certificate

Rajendra Institute of Medical Sciences cancels admission of first-year MBBS student after probe confirms fraudulent SC certificate. Two similar cases detected in Daltonganj. Read the full investigation details.

418 New PG Medical Seats Approved in Tamil Nadu Colleges

National Medical Commission approves 418 additional PG seats in Tamil Nadu's private medical colleges. New seats include anaesthesiology, general medicine & surgery. State aims to add seats in second counselling round.

Odisha Raises Maoist Bounties 10% Above Chhattisgarh

Odisha government increases Maoist surrender rewards by 10% over Chhattisgarh rates. New policy offers up to ₹1.20 crore for top leaders to combat Left-Wing Extremism. Read more about the strategy.

NMC Lacks Data on Hospitals for Medical Residency

National Medical Commission admits having no exact data on hospitals with 220-499 beds despite new residency rules. Medical students face uncertainty about career planning. Learn more about this regulatory gap.

India GCCs Focus on Innovation Over Scale in AI Era

India's Global Capability Centres are shifting from hiring numbers to innovation-driven outcomes. Pharma and fintech leaders reveal bold strategies prioritizing AI and blockchain over cost arbitrage.

Page 1 of 4